Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II
Frankfurt, Germany
University hospital in Frankfurt, Hessen
Theodor-Stern-Kai 7, 60596 Frankfurt am Main
About Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II
During the past decade, Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
2007-08-01
2017-09-07
Completed
674
Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
2009-08-01
2016-02-01
Completed
213
Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia
2011-01-01
2013-05-01
Terminated
56
Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
2015-07-01
2019-02-21
Terminated
148
A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma
2015-06-01
2021-06-24
Completed
564
Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)
2018-10-18
2025-12-01
Active, not recruiting
662
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II
According to Clinical.Site data, the most researched conditions in "Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II" are
"Multiple Myeloma" (2 trials), "Acute Lymphoblastic Leukaemia" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Kidney Neoplasms" (1 trials). Many other conditions were trialed in "Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II
Most popular intervention types in "Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (2 trials), "Dexamethasone" (2 trials), "Lenalidomide" (2 trials), "Azacitidine" (1 trials) and "Cytarabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II
The vast majority of trials in "Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II" are
6 trials for "All" genders.
Clinical Trials Status at Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II
Currently, there are NaN active trials in "Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".